The Food and Drug Administration (FDA) has approved a new device that can help control the symptoms of Parkinson's disease and those who suffer from the disease can think about another treatment.

The disease is a common neurological disorder and at least a million people in the United States are affected by the disease. And each year, over 50,000 cases are diagnosed.

The brain is accountable for every movement as the control center of the body; it sends instructions with help of its neurotransmitters to the various nerves of the body. Dopamine is one of these neurotransmitters, which controls motion.

According to William Maisel, acting director of the Office of Device Evaluation at the FDA’s Center for Devices and Radiological Health, “There are no cures for Parkinson’s disease or essential tremor, but finding better ways to manage symptoms is essential for patients. This new device adds to the array of treatment options to help people living with Parkinson’s and essential tremor enjoy better, more productive lives”.

It is not clear why the nerve cells that produce the neurotransmitter deteriorate and are not able to produce dopamine in the process. As a result, the patient is not able to control his movements anymore.

There are already some medications that can help control the symptoms but all of the patients don’t respond well, so they can still have the tremors.

Now, the stimulation device called Neurostimulation System could be used as a supplement to the medications. The device has been created by St. Jude Medical, and uses batteries to operate; it can be implanted close to the upper area of the chest and below the skin.